skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Good morning and Merry Chrstmas 5i. Your past comments on Pure indicate that you believe there is a very low % of a better offer. I would tend to agree accept for the current price of the shares being so close to the offer price. Shares have traded above 8.90 since the offer and today shares hit 8.99. Obviously a buyer at that price would have to believe there is more at play here. Has your view changed based on this?
Read Answer Asked by Robert on December 20, 2017
Q: I guess I'll hold on until the dividend date. But PUR was one of my largest positions even before the takeover offer. As such it is now about 10% of my portfolio. My question is how long do you think the takeover will take and in my position, would you just err on the side of safety and take the considerable money and run. Also, although I have held PUR for a long time, your continued endorsement of the company made it easier to continue to hold through the recent drop and I thank-you for that.
Read Answer Asked by Alex on December 13, 2017
Q: Hi Peter,

Thank you for your new design and continued service. I have decided to sell PUR in my TFSA ($5k) and take the profit and reinvest. I was looking at growth stocks in Canada and did not like the alternatives (maybe ZCL or SHOP). My options appear to be in the USA or Asia. IF you could choose one growth stock (even a CDN one), which stock would you choose for a TFSA.
We have KXS, SYZ, AQN, FTS, FSZ, MFC, BNS, SIS

Thank you
Jerry and Debbie
Read Answer Asked by Jerry on December 13, 2017
Q: I looked at PUR, liked the business, but found it pricey and chose to wait. A bad call I suppose. I realize Xylem will realize cost savings on the acquisition, and will no doubt see opportunities to expand PUR's business within its portfolio, but please help me understand something. I estimate Xylem is paying over 20 times PUR's expected 2017 EBITDA. I thought 10 to 11 times was "high". Isn't $9.00 exceptionally pricey? What can I take away from this? Thank you for your time. Edward.
Read Answer Asked by Edward on December 12, 2017
Q: What would you suggest to replace PUR, in comparable sector and market cap and any other best option at this time.
Read Answer Asked by David on December 11, 2017
Q: Amongst other names I hold the above noted names and am wondering if you think I should exit any of the names listed or hold on as all have done relatively poorly? Thanks, Ian
Read Answer Asked by Ian on November 21, 2017
Q: Hi. PUR is down about 12% over the last couple of days on their 3rd Q results. In the past, you have indicated that the business can be a little lumpy. With the conference call in mind, is this an opportunity to increase my holdings in the company, or should I consider paring back, or should I simply maintain my holdings until their next financial report?
Read Answer Asked by Alan on November 09, 2017
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!